H&R GmbH KGaA (BATS-CHIXE:2HRAD) - Stock Price, News & Analysis

2HRAD Stock Overview

Engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts. More details

2HRAD fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	2/6
Financial Health	4/6
Dividends	0/6

Rewards

Trading at 21.5% below our estimate of its fair value

Risk Analysis

Earnings are forecast to decline by an average of 47.8% per year for the next 3 years

Shares are highly illiquid

Profit margins (2.8%) are lower than last year (4.8%)

H&R GmbH & Co. KGaA Competitors

Treatt

LSE:TET

UK£255.9m

Victrex

LSE:VCT

UK£763.5m

Iofina

AIM:IOF

UK£36.5m

Johnson Matthey

LSE:JMAT

UK£2.6b

Price History & Performance

Summary of all time highs, changes and price drops for H&R GmbH KGaA
Historical stock prices
Current Share Price	€6.44
52 Week High	€6.54
52 Week Low	€6.44
Beta	1.28
11 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	32.51%
5 Year Change	-55.11%
Change since IPO	-57.22%

Recent updates

Shareholder Returns

	2HRAD	GB Chemicals	GB Market
7D	0%	-2.6%	0.8%
1Y	n/a	-18.9%	6.6%

Return vs Industry: Insufficient data to determine how 2HRAD performed against the UK Chemicals industry.

Return vs Market: Insufficient data to determine how 2HRAD performed against the UK Market.

Price Volatility

Is 2HRAD's price volatile compared to industry and market?
2HRAD volatility
2HRAD Average Weekly Movement	n/a
Chemicals Industry Average Movement	5.6%
Market Average Movement	4.7%
10% most volatile stocks in GB Market	10.3%
10% least volatile stocks in GB Market	2.6%

Stable Share Price: 2HRAD has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine 2HRAD's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1919	1,657	Niels Hansen	www.hur.com

H&R GmbH & Co. KGaA manufactures and sells chemical-pharmaceutical raw materials and injection molded precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other crude oil-based specialty products, as well as feedstocks and bunker fuels.

H&R GmbH & Co. KGaA Fundamentals Summary

How do H&R GmbH KGaA's earnings and revenue compare to its market cap?
2HRAD fundamental statistics
Market cap	€235.99m
Earnings (TTM)	€43.26m
Revenue (TTM)	€1.54b

5.5x

P/E Ratio

0.2x

P/S Ratio

Is 2HRAD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2HRAD income statement (TTM)
Revenue	€1.54b
Cost of Revenue	€1.22b
Gross Profit	€323.82m
Other Expenses	€280.56m
Earnings	€43.26m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	1.16
Gross Margin	21.03%
Net Profit Margin	2.81%
Debt/Equity Ratio	42.2%

How did 2HRAD perform over the long term?

See historical performance and comparison

H&R GmbH KGaA BATS-CHIXE:2HRAD Stock Report